Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of November 14, 2026, LLY trades at $1,443.50 with a market cap of $1.29T and a P/E ratio of 38.84. LLY moved +0.89% today. Year to date, LLY is +38.60%; over the trailing twelve months it is +41.12%. Its 52-week range spans $623.78 to $1,460.00. Analyst consensus is strong buy with an average price target of $1,511.30. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Eli Lilly (LLY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LLY moved +0.89% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $1,443.50 |
| Market Cap | $1.29T |
| P/E Ratio | 38.84 |
| EPS | $29.84 |
| Dividend Yield | 1.73% |
| 52-Week High | $1,460.00 |
| 52-Week Low | $623.78 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $79.67B |
| Net Income | $26.71B |
| Gross Margin | 83.40% |
24 analysts cover LLY: 0 strong buy, 22 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,511.30.